929360081000036101: Medicinal product pack reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product pack reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product pack reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1740441059
Medicinal product pack reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	991480534
Medicinal product pack reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

pazopanib 200 mg tablet, 30

pazopanib 200 mg tablet, 90

pazopanib 400 mg tablet, 30

pazopanib 400 mg tablet, 60

pegaspargase 3750 units injection, 1 vial

pegaspargase 3750 units/5 mL injection, 5 mL vial

pegcetacoplan 1.08 g/20 mL injection, 20 mL vial

pegcetacoplan 1.08 g/20 mL injection, 8 x 20 mL vials

pegfilgrastim 6 mg/0.6 mL injection, 0.6 mL syringe

peginterferon alfa-2a 135 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [112], 1 pack

peginterferon alfa-2a 135 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [140], 1 pack

peginterferon alfa-2a 135 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [168], 1 pack

peginterferon alfa-2a 135 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [84], 1 pack

peginterferon alfa-2a 135 microgram/0.5 mL injection, 4 x 0.5 mL syringes

peginterferon alfa-2a 180 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [112], 1 pack

peginterferon alfa-2a 180 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [140], 1 pack

peginterferon alfa-2a 180 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [168], 1 pack

peginterferon alfa-2a 180 microgram/0.5 mL injection [4 x 0.5 mL syringes] (&) ribavirin 200 mg tablet [84], 1 pack

peginterferon alfa-2a 180 microgram/0.5 mL injection, 4 x 0.5 mL syringes

peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device

peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices

peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [112], 1 pack

peginterferon alfa-2b 100 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack

peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device

peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices

peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack

peginterferon alfa-2b 120 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack

peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device

peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices

peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack

peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [168], 1 pack

peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [196], 1 pack

peginterferon alfa-2b 150 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack

peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device

peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices

peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [112], 1 pack

peginterferon alfa-2b 50 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack

peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 1 dual chamber pen device

peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], 4 dual chamber pen devices

peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [140], 1 pack

peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [168], 1 pack

peginterferon alfa-2b 80 microgram injection [1 chamber] (&) inert substance diluent [0.5 mL chamber], [4 dual chamber pen devices] (&) ribavirin 200 mg capsule [84], 1 pack

peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices

peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL syringes

peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL pen device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL pen device], 1 pack

peginterferon beta-1a 63 microgram / 0.5 mL injection [1 x 0.5 mL syringe] (&) peginterferon beta-1a 94 microgram / 0.5 mL injection [1 x 0.5 mL syringe], 1 pack (medicinal product pack)

peginterferon beta-1a 63 microgram/0.5 mL injection, 0.5 mL pen device

peginterferon beta-1a 63 microgram/0.5 mL injection, 0.5 mL syringe

peginterferon beta-1a 94 microgram/0.5 mL injection, 0.5 mL pen device

peginterferon beta-1a 94 microgram/0.5 mL injection, 0.5 mL syringe

pegvaliase 10 mg/0.5 mL injection, 0.5 mL syringe

pegvaliase 2.5 mg/0.5 mL injection, 0.5 mL syringe

pegvaliase 20 mg/mL injection, 1 mL syringe

pegvaliase 20 mg/mL injection, 10 x 1 mL syringes

pembrolizumab 100 mg/4 mL injection, 4 mL vial

pembrolizumab 50 mg injection, 1 vial

pemetrexed 1 g/40 mL injection, 40 mL vial

pemetrexed 1 g injection, 1 vial

pemetrexed 100 mg/4 mL injection, 4 mL vial

pemetrexed 100 mg injection, 1 vial

pemetrexed 500 mg/20 mL injection, 20 mL vial

pemetrexed 500 mg injection, 1 vial

penciclovir 1% cream, 2 g

penciclovir 1% cream, 5 g

penicillamine 125 mg tablet, 100

penicillamine 250 mg tablet, 100

pentamidine isetionate 300 mg injection, 1 vial

pentetreotide 10 microgram injection, 1 vial

pentosan polysulfate sodium 100 mg capsule, 100

pentoxifylline 400 mg modified release tablet, 30

pentoxifylline 400 mg modified release tablet, 50

pentoxyverine citrate 15 mg/10 mL oral liquid, 100 mL

pentoxyverine citrate 15 mg/10 mL oral liquid, 200 mL

peppermint oil 0.2 mL enteric capsule, 10

peppermint oil 0.2 mL enteric capsule, 20

peppermint oil 0.2 mL enteric capsule, 30

peppermint oil 0.2 mL enteric capsule, 60

peppermint oil 0.2 mL enteric capsule, 90

peppermint water oral liquid, 100 mL

peramivir 200 mg/20 mL injection, 3 x 20 mL vials

perampanel 10 mg tablet, 28

perampanel 12 mg tablet, 28

perampanel 2 mg/4 mL oral liquid, 340 mL

perampanel 2 mg tablet, 7

perampanel 4 mg tablet, 28

perampanel 6 mg tablet, 28

perampanel 8 mg tablet, 28

perfluorohexyloctane 100% eye drops, 3 mL

perfluorohexyloctane 30.5% + polydimethyl siloxane 69.5% implant, 1

perflutren 1.1 mg/mL injection, 4 vials

pergolide 1 mg tablet, 100

pergolide 250 microgram tablet, 100

pergolide 50 microgram tablet, 100

perhexiline maleate 100 mg tablet, 100

periciazine 10 mg tablet, 100

periciazine 10 mg tablet, 84 tablets (medicinal product pack)

periciazine 2.5 mg tablet, 100

periciazine 2.5 mg tablet, 84

perindopril arginine 10 mg tablet, 10

perindopril arginine 10 mg tablet, 100

perindopril arginine 10 mg tablet, 30

Start Previous Page 128 of 160 Next End

Reference Sets

Reference set descriptor